Non-covalent metallo-drugs: using shape to target DNA and RNA junctions and other nucleic acid structures

Lucia Cardo, Michael J Hannon

Research output: Chapter in Book/Report/Conference proceedingChapter (peer-reviewed)peer-review

Abstract

The most effective class of anticancer drugs in clinical use are the platins which act by binding to duplex B-DNA. Yet duplex DNA is not DNA in its active form, and many other structures are formed in cells; for example, Y-shaped fork structures are involved in DNA replication and transcription and 4-way junctions with DNA repair. In this chapter we explore how large, cationic metallo-supramolecular structures can be used to bind to these less common, yet active, nucleic acid structures.

Original languageEnglish
Title of host publicationMetallo-drugs
Subtitle of host publicationDevelopment and Action of Anticancer Agents
PublisherWalter de Gruyter GmbH & Co. KG
Chapter11
Pages303-324
Number of pages22
ISBN (Electronic)9783110470734
DOIs
Publication statusPublished - 5 Feb 2018

Publication series

NameMetal Ions in Life Sciences
Volume18
ISSN (Print)1559-0836
ISSN (Electronic)1868-0402

Keywords

  • Animals
  • Antineoplastic Agents/chemistry
  • Binding Sites
  • Coordination Complexes
  • DNA, Neoplasm/chemistry
  • Drug Design
  • G-Quadruplexes
  • Humans
  • Models, Molecular
  • Neoplasms/drug therapy
  • Nucleic Acid Conformation
  • Organometallic Compounds/chemistry
  • RNA, Neoplasm/chemistry
  • Structure-Activity Relationship

Fingerprint

Dive into the research topics of 'Non-covalent metallo-drugs: using shape to target DNA and RNA junctions and other nucleic acid structures'. Together they form a unique fingerprint.

Cite this